A Phase I/II Study of TJ004309 for Advanced Solid Tumor

NCT04322006 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TJ004309
DRUG: Toripalimab

Sponsor

TJ Biopharma Co., Ltd.